Relapsed Refractory Multiple Myeloma (RRMM), Proteasome Inhibitors (PI), Carfilzomib Maintenance, No Maintenance, Phase 2, 1 prior line of therapy
### Instruction:
Identify the study with the following condition. 
### Input:
Relapsed Refractory Multiple Myeloma (RRMM), Proteasome Inhibitors (PI), Carfilzomib Maintenance, No Maintenance, Phase 2, 1 prior line of therapy 
### Output:
Popular Name is MUK Five, Study ID is ISRCTN17354232